does not provide readily identifiable benefits to African Americans with hypertensive nephrosclerosis. Importantly, this study provides the basis for the primary use of angiotensin-converting ...
Where does the AASK trial take the practicing clinician? It should be clear from the AASK trial data that ACE inhibitor therapy is important in the African American patient with hypertensive ...
Diabetes leads to diabetic nephropathy due to high blood sugar levels, while hypertension causes nephrosclerosis by straining renal arteries and reducing blood flow to the kidneys. Polycystic ...